Delivery Order SPE2DR25D6029-SPE2DR26FXR2W
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,808.25 to AmerisourceBergen Drug Corp for the supply of Linezolid 600 mg tablets (20-count packages) on January 7, 2026, with an ultimate completion date of January 8, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Linezolid 600 mg tablets in quantities of 20s with a ceiling value of $8,322.43. This firm fixed price delivery order, which carries an ultimate completion date of September 9, 2025, is unset-aside and competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 600 mg Linezolid tablets. The contract has a ceiling value of $1,507.56 and a period of performance ending on April 23, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LINEZOLID 600 MG TABLET 20S. The firm-fixed-price contract has a ceiling value of $5,304.04 and an ultimate completion date of August 27, 2024. AmerisourceBergen holds a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a comprehensive range of medical...
- This federal contract award, valued at $4,816.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the procurement of 4567557619 - LINEZOLID 600 MG TABLET 20S, with a period of performance running through March 13, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of LINEZOLID 600 MG TABLET 20S. The contract, valued at $12,003.54, was awarded by the Defense Logistics Agency (DLA), a defense agency, and is a Firm Fixed Price Delivery Order with a completion date of June 11, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,159,591 tablets of 600 mg Linezolid, a generic antibiotic medication. The $2,582.83 order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical...
- Defense Logistics Agency awarded a $422 firm fixed price delivery order to Amerisourcebergen Drug Corp for the provision of 20 tablets of 600mg linezolid per package. The place of performance is Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation, which will perform as the prime contractor. No set-aside designation was used for this order. The completion date is September 25, 2023. This supports DLA's mission to provide pharmaceuticals and other...
- The Defense Logistics Agency Troop Support Medical awarded a $844 delivery order to Amerisourcebergen Drug Corp for 600 mg tablets of linezolid. As the prime contractor, Amerisourcebergen will deliver 20 tablets of the antibiotic to a facility in Conshohocken, Pennsylvania by July 10, 2023 to fulfill requirements under the Prime Vendor Program contract vehicle. No subcontractors or set aside designations were indicated. The order supports DLA Troop Support Medical's mission to procure and...
- This delivery order against an unspecified government-wide acquisition contract awards Amerisourcebergen Drug Corporation $579 to supply 4562319621 LINEZOLID 600 MG/300 ML-D5W 300ML to the Defense Logistics Agency by September 27, 2023. As the corporate office of Amerisourcebergen Corporation, the awardee will deliver the requested pharmaceutical product to the agency's location in Conshohocken, Pennsylvania under firm fixed pricing terms. No set-aside designation was applied to this order to...
- SPE2DR25D6029Indefinite Delivery Contract
- SPE2DR25D6029-SPE2DR26FXR2WDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,114.30 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 9, 2026, for the supply of Linezolid 600 mg tablets in quantities of 20 units. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. Performance will be completed at the awardee's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 12, 2026. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2031. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. Linezolid is a broad-spectrum antibiotic commonly used in military medical supply chains to address serious infections. The award reflects the company's established capability to deliver essential pharmaceutical commodities through the DLA's comprehensive pharmaceutical supply vehicle, which enables efficient fulfillment of medical requirements across military treatment facilities and federal healthcare institutions worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 1/8/26 |